Chief Executive Officer
CurrentAbera develops innovative vaccines based on proprietary and patented platform technologies. The vaccine candidates can be administered as nasal sprays and are fast and cost-effective to develop and produce. Using its platform technologies, the company has developed several vaccine candidates with current focus on pneumococcal vaccines and pandemic preparedness.